Search
for
Did you mean Serum Levels?
Community 10 of 375
- My case study: DHT serum levels unresponsive to higher topical fin dosages.
- 14 months on Fin, Total T 899, serum DHT 276 — high total T may still drive scalp DHT even when blood levels look controlled
- Dutasteride mesotherapy doesn’t impact your bodies serum hormone levels?
- Is there a known amount of fin that can reduce serum DHT by only around 25% over the longer term?
- Ultimate DHT/finasteride microdosing graph to replace the commonly one referenced on forums
- Everyone is ignoring that plasma finasteride levels are 100x lower with topical compared to oral.
- Unexpected Serum DHT Elevation after Generic Dutasteride Use.
- Research Backed Dutasteride Simulator (Serum/scalp DHT included for all doses)
- 800pg/mL serum DHT after almost 2 years on dht blockers
- Topical Dutasteride. Does it work?
Research 10 of 1000+
- associations between serum dihydrotestosterone levels, lipid parameters & anthropometric measurements in male patients with type 2 diabetes mellitus
- The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
- Serum dihydrotestosterone levels are associated with adverse myocardial remodeling in patients with severe aortic valve stenosis before and after aortic valve replacement
- Sex steroid levels in corresponding cerebrospinal fluid and serum samples quantified by mass spectrometry in men
- Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
- BENIGN PREMATURE ADRENARCHE: CLINICAL FEATURES AND SERUM STEROID LEVELS
- S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION?
- Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men
- Role of serum androgens and prostate-specific antigen levels in males with androgenetic alopecia
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels